Latent Genetic Backgrounds and Molecular Pathogenesis in Drug-Induced Long-QT Syndrome
BACKGROUND—Drugs with IKr-blocking action cause secondary long-QT syndrome. Several cases have been associated with mutations of genes coding cardiac ion channels, but their frequency among patients affected by drug-induced long-QT syndrome (dLQTS) and the resultant molecular effects remain unknown....
Gespeichert in:
Veröffentlicht in: | Circulation. Arrhythmia and electrophysiology 2009-10, Vol.2 (5), p.511-523 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!